Concepedia

Bryan Clemons

BC

Statistics

Publications

7

Citations

1.2K

H-Index

7

Active since

2008

Affiliations

Scripps Research Institute(Current)

Acadia Pharmaceuticals (United States)

Bryan Clemons is an author at Scripps Research Institute specializing in pharmacology, molecular pharmacology, and medicine.

Publications per year

2008–2022

7

Publications

7

Crystal Structure of a Lipid G Protein–Coupled Receptor

Michael A. Hanson, C. Roth, Euijung Jo et al. · Science · 2012 · 668 citations

, , +17

Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P <sub>1</sub> ) and receptor‐5 (S1P <sub>5</sub> ) agonist with autoimmune disease‐modifying activity

Fiona L. Scott, Bryan Clemons, Jennifer L. Brooks et al. · British Journal of Pharmacology · 2016 · 305 citations · Full text

, , +15

Actions of a picomolar short-acting S1P1 agonist in S1P1-eGFP knock-in mice

Stuart M. Cahalan, Pedro J. Gonzalez‐Cabrera, Gor Sarkisyan et al. · Nature Chemical Biology · 2011 · 81 citations

, , +5

Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension

Anna Galkin, Ravikumar Sitapara, Bryan Clemons et al. · European Respiratory Journal · 2022 · 68 citations · Full text

, , +13

Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists

Luis R. Gardell, Jian-Nong Ma, Jimmi Gerner Seitzberg et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 52 citations

, , +7

1–5 of 7